Archive for the 'New Study' Category

New Study news feed.

MicroRNA Could be used to Quickly Diagnose Mesothelioma

Biomarkers are measureable substances that indicate if someone has a disease. Doctors and researchers are able to find different substances within a person’s body and deduce that the person has a specific type of cancer. Researchers have found a relatively new biomarker called microRNA, which could possibly be used to diagnose mesothelioma. MicroRNAs control gene

more

Mesothelioma Diagnosis Rates Have Remained Stable even though Mesothelioma Survival has Improved

It was found that the number of pleural mesothelioma diagnoses has stayed the same, while the survival rate for people with the disease has slightly improved. Once asbestos was not used as much because of multiple regulations, the number of diagnoses of mesothelioma was predicted to go down. Instead, the number of diagnoses has remained

more

The Ketogenic Diet Could be used to Slow Cancer Growth

According to a study done at The University of Texas at Dallas, the Ketogenic diet, which is very low in sugar, as well as the administration of a diabetes drug that prevents glucose in the blood from being adsorbed by the kidneys, slowed down the growth of squamous cell carcinoma tumors in mice.  This specific

more

Potential New Treatment Acts as a Sealant for Pleural Mesothelioma Tumors

Pleural mesothelioma, caused by exposure to asbestos is a rare cancer – only 3,000 cases are diagnosed in the U.S. each year – but it is highly aggressive. There is no cure for plural mesothelioma but findings published in the Journal of Thoracic and Cardiovascular Surgery reveal that a new type of combination treatment specifically

more

First FDA Approved Treatment for Mesothelioma in 15 Years

In the Fall of 2018 scientists and researchers from Novocure, an oncology company that specializes in treating solid tumors, were hopeful their latest success with Tumor Treating Fields therapy would lead to FDA approval and ultimately, more options for those suffering from mesothelioma. After a successful clinical trial, these hopes became a reality as the

more

Currently Recruiting: Mesothelioma Clinical Trials

When it comes to effective mesothelioma treatments, options are unfortunately limited. There is no cure for mesothelioma and first line chemotherapy treatment Alimta, is no guarantee.  Many who are suffering from mesothelioma, who have found little or no comfort in traditional treatments, may turn to clinical trials for hope.  Through clinical trials, patients have access

more

Mesothelioma Patient Survival Potentially Doubles with Targeted Radiotherapy

Radiotherapy, also known as radiation therapy, is a type of cancer treatment that uses ionizing radiation to kill cancer cells by damaging the cell’s DNA. It can be used as either a curative or palliative treatment and is often used alongside chemotherapy, either before, during, or after. Radiotherapy can be especially successful in some cancer

more

Nomogram May More Accurately Predict Mesothelioma Survival

Predicting pleural mesothelioma survival is a difficult task, as a number of factors are needed to make an accurate calculation. Currently, the TNM Staging system in place as one of the ways to predict life-expectancy and survival after a mesothelioma patient has had surgery. However, researchers from Peking University in China have recently discovered what

more

Less Invasive Surgery Produces Longer Median Survival in Mesothelioma Patients

Surgical techniques for those suffering from mesothelioma depend on how far the cancer has spread and if the patient is healthy enough to withstand such an invasive procedure. In many cases, the cancer has already spread too far and quickly, so surgery is not an option. For those able to treat their cancer with surgery,

more

Targeted Immunotherapy Warrants More Research for Those Suffering from Pleural Mesothelioma

Late last month, the Clinical Respiratory Journal released their findings on the efficacy of intrapleural immunotherapy, which is a highly targeted approach of receiving immunotherapy treatment for those suffering from mesothelioma. Mesothelioma is a cancer caused only by asbestos exposure. Since asbestos is the only known cause, mesothelioma is sometimes referred to as “asbestos cancer.”

more

New Clinical Trial Underway for Immunotherapy Treatment; CA-170

A new immunotherapy treatment that has recently been administered to a patient suffering from mesothelioma has researchers and scientists optimistic that if results are positive, this treatment could be more effective than Keytruda, the immunotherapy treatment that has had major success in non-small cell lung cancer  The name of the treatment is CA-170, and while

more

Quality of Life After Pleurectomy/Decortication vs. Extra Pleural Pneumonectomy

On the rare instance that mesothelioma is diagnosed in the early stages of the disease, patients have the option for surgery.  There are several surgical procedures used to treat mesothelioma. Some mesothelioma surgeries aim to provide a curative effect, while others are performed for palliative purposes. Pleurectomy/decortication (P/D) and extra pleural pneumonectomy (EPP) are two

more

Decade Long Study Reveals Potential for Early Detection in Mesothelioma

For many patients who are suffering from malignant mesothelioma, their diagnosis came quickly after experiencing symptoms. In many cases, this is because symptoms of mesothelioma typically do not appear until the cancer has fully developed and it’s in the later stages. For those suffering from pleural mesothelioma – the most common type – 90 percent

more

Researchers Theorize Drug from the 1800s Could Improve Radiation Treatments in Mesothelioma Patients

Radiation therapy for those suffering from mesothelioma is not typically the first line of treatment because of its overall effectiveness. High-energy x-rays, gamma rays, and neutrons that make up radiation treatment aim to shrink tumors and ultimately kill cancer cells, but since mesothelioma tumors often have an irregular shape, it can be difficult to target

more

Survival Improves in Mesothelioma Patients who Received an Electricity-Based Treatment

The success of a recent Phase II clinical trial in malignant pleural mesothelioma has scientists and researchers excited about the possibility of adding a new treatment that will not only improve survival, but also improve quality of life of the cancer patient. Tumor Treating Fields, which is a therapy that uses alternating electric fields to

more

Last update: April 01, 2019. 03:30:08 pm.